Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $145,159 - $531,150
109,969 New
109,969 $151,000
Q3 2022

Nov 14, 2022

BUY
$3.75 - $7.39 $228,491 - $450,280
60,931 Added 414.5%
75,631 $480,000
Q2 2022

Aug 15, 2022

SELL
$2.94 - $5.23 $558,600 - $993,700
-190,000 Reduced 92.82%
14,700 $61,000
Q1 2022

May 16, 2022

BUY
$4.07 - $10.6 $787,952 - $2.05 Million
193,600 Added 1744.14%
204,700 $993,000
Q4 2021

Feb 14, 2022

BUY
$8.96 - $16.31 $99,456 - $181,041
11,100 New
11,100 $111,000
Q3 2021

Nov 16, 2021

SELL
$11.24 - $21.0 $242,840 - $453,705
-21,605 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.04 - $22.09 $261,652 - $320,393
14,504 Added 204.25%
21,605 $691,000
Q1 2021

May 17, 2021

BUY
$16.59 - $33.89 $117,805 - $240,652
7,101 New
7,101 $214,000
Q4 2020

Feb 16, 2021

SELL
$27.5 - $37.92 $181,940 - $250,878
-6,616 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$34.44 - $43.75 $227,855 - $289,450
6,616 New
6,616 $357,000
Q2 2020

Aug 14, 2020

SELL
$27.12 - $45.97 $191,385 - $324,410
-7,057 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$26.16 - $63.5 $210,640 - $511,302
-8,052 Reduced 53.29%
7,057 $324,000
Q4 2019

Feb 14, 2020

BUY
$46.96 - $61.67 $709,518 - $931,772
15,109 New
15,109 $1.33 Million
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $1.16 Million - $1.53 Million
-13,000 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $1.3 Million - $1.66 Million
13,000 New
13,000 $2.04 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $485M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.